Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756840
What this trial is testing

Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Who this might be right for
Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus Infection+3 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00601796
What this trial is testing

Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 24
Early research (Phase 1)Study completedNCT00001096
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Testing effectiveness (Phase 2)UnknownNCT01584115
What this trial is testing

Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Who this might be right for
Cancer.Melanoma.Ovarian Cancer.+1 more
Instituto de Investigação em Imunologia 15
Early research (Phase 1)Study completedNCT00140738
What this trial is testing

Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 3
Testing effectiveness (Phase 2)UnknownNCT04800978
What this trial is testing

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
Samsung Medical Center 37
Large-scale testing (Phase 3)Study completedNCT02446743
What this trial is testing

Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 531
Post-approval studies (Phase 4)UnknownNCT05079152
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4

Who this might be right for
Influenza, HumanPneumonia, PneumococcalCOVID-19 Pneumonia
China National Biotec Group Company Limited 1,404
Early research (Phase 1)Looking for participantsNCT06026774
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms

Who this might be right for
Digestive System Neoplasms
Sir Run Run Shaw Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01433172
What this trial is testing

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

Who this might be right for
Lung CancerAdenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 73
Testing effectiveness (Phase 2)WithdrawnNCT04267237
What this trial is testing

The Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche
Early research (Phase 1)Ended earlyNCT02452775
What this trial is testing

Autologous OC-L Vaccine and Ovarian Cancer

Who this might be right for
Primary Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 3
Large-scale testing (Phase 3)UnknownNCT04642339
What this trial is testing

Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela

Who this might be right for
Covid19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 2,000
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Large-scale testing (Phase 3)Not Yet RecruitingNCT07041190
What this trial is testing

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Who this might be right for
RSV Immunization
PENTA Foundation 1,500
Early research (Phase 1)UnknownNCT05202561
What this trial is testing

RNA Tumor Vaccine in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
The First Affiliated Hospital of Bengbu Medical University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015724
What this trial is testing

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaRefractory Non-Small Cell Lung Cancer
Georgetown University 19
Early research (Phase 1)Active Not RecruitingNCT04117087
What this trial is testing

Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Large-scale testing (Phase 3)Study completedNCT01948193
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 177
Next Page